Company news

Anatara Lifesciences Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Appendix 4C & Q1 FY24 Activities Report

October 31, 2023

Webinar Investor Presentation

October 18, 2023

Anatara IBS trial positive secondary endpoint data analysis

October 16, 2023

ANR announces Positive Results from Stage 1 of IBS trial

September 28, 2023

IBS clinical trial Stage 1 patients finalised

August 30, 2023

Appendix 4E & Audited Financial Statements 30 June 2023

August 23, 2023

$923,235 in R&D tax incentive received

August 13, 2023

Appendix 4C & Q4 FY23 Activities Report

July 31, 2023

Anatara Update on GaRP Irritable Bowel Syndrome Trial

June 5, 2023

Appendix 4C & Q3 FY23 Activities Report

April 19, 2023

Anatara Company Update

March 9, 2023

Half Yearly Report and Accounts

February 23, 2023

Placement of Shortfall from Entitlement Offer

February 21, 2023

Revised Appendix 4C

January 13, 2023

Appendix 4C & Q2 FY23 Activities Report

January 11, 2023

Completion of Non-renounceable Entitlement Offer and Shortfa

November 24, 2022

Appendix 4C & Q1 FY23 Activities Report

October 27, 2022

Placement and Entitlement Offer

October 20, 2022

Entitlement Offer Prospectus

October 20, 2022

Anatara Investor Presentation

October 13, 2022

3FDC Clinical Trial update

October 2, 2022

Appendix 4E & Audited Financial Report 30 June 2022

August 29, 2022

Operational Update

August 10, 2022

Q4 FY22 Activities Report

July 31, 2022

Quarterly Appendix 4C Cash Flow Report

July 29, 2022

Clinical Trial and Operational Update

May 19, 2022

Anatara Lifesciences announces leadership change

May 5, 2022

Appendix 4C and Q3 FY22 Activities Report

April 28, 2022

Clinical Trials Update

March 30, 2022

Half Year Accounts

February 23, 2022

Appendix 4C and Q2 FY22 Activities Report

January 27, 2022

Change of Director's Interest Notice

December 12, 2021

Notification regarding unquoted securities - ANR

December 12, 2021

Application for quotation of securities - ANR

December 9, 2021

AGM CEO Presentation

November 16, 2021

Chairmans Address to Shareholders

November 16, 2021

AGM CEO Presentation

November 15, 2021

Appendix 4C & Q1 FY22 Activities Report

October 29, 2021

Anatara Lifesciences Limited (ASX: ANR) Annual Report to Shareholders

October 15, 2021

Investor Presentation

September 5, 2021

Appendix 4E & Financial Report 30 June 2021

August 24, 2021

Anatara Lifesciences Limited (ASX: ANR) Launches IBS-D Clinical Trial Recruitment Website

August 19, 2021

Successful Piglet Study

August 5, 2021

Monthly Activities/Appendix 4C Cash Flow Report

July 28, 2021

Anatara Lifesciences Limited (ASX: ANR) Monthly Activities Report

July 27, 2021

Anatara Lifesciences Limited (ASX: ANR) Chair Transition

July 25, 2021

Appendix 4C - quarterly

April 26, 2021

Anatara announces Australian patent grant for Detach

April 15, 2021

Market Update

April 7, 2021

Anatara Lifesciences Ltd (ASX: ANR) Completion of Unmarketable Parcel Share Buy-Back

February 9, 2021

← Newer news releases · Older news releases →

Decks

The 5 newest of 35 decks. Every deck is listed under its year.